Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 560 across all filing types
Latest filing 2023-08-18 Capital/Financing Update
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
LUMIBIRD : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Capital/Financing Update Classification · 95% confidence The document is titled "LUMIBIRD : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (LUMIBIRD: SEMI-ANNUAL REPORT ON THE LIQUIDITY CONTRACT). It details the status of the liquidity contract (shares and cash held by the agent) as of June 30, 2023, and summarizes the transactions (purchases and sales) executed during the first semester of 2023. This is a periodic report specifically detailing the activity related to a market stabilization/liquidity agreement, which is a specific type of corporate disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Interim Report (IR). Since it is a specific report detailing the status of a financial arrangement (liquidity contract) at a specific reporting date (semestriel/half-year), it fits best under a specialized category. Given the options, it is a specific financial/corporate disclosure. It is not a general regulatory filing (RNS) because it is highly specific. It is not a transaction in own shares (POS) as it reports on the *liquidity provider's* activity, not the company's direct buyback program, although related. It is a periodic report on a specific financial arrangement. Since there is no explicit 'Liquidity Contract Report' code, we must choose the closest fit. This document reports on the status of shares held for market purposes, which is related to capital management and share activity. However, the core content is a periodic summary of a specific agreement. Given the definitions, this type of periodic disclosure, which is not a full financial statement or earnings release, often falls under general corporate information or regulatory filings. Since it is a formal, periodic report on a specific financial mechanism, and not a general announcement of a report's release, it is not RPA. It is a specific disclosure. If we consider the nature of the activity (managing share availability), it relates to share capital, but it's a report on the *contract*. In the absence of a better fit, and recognizing it as a formal, periodic corporate disclosure, 'Regulatory Filings' (RNS) serves as the best general category for specific, non-standard periodic reports, or we must consider if it relates to share transactions (POS). Since it is a report *about* the liquidity contract, not the company executing a buyback, POS is less accurate. RNS is the most appropriate fallback for specific, non-standard periodic corporate disclosures that don't fit the primary financial/management categories.
2023-08-18 French
LUMIBIRD : nombre d'actions au 31 juillet 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (935 characters) and presents a table detailing the total number of voting rights and shares as of July 31, 2023, referencing French regulatory articles (Code de commerce and AMF General Regulation). This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement in France. It does not fit the definition of a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is a specific regulatory disclosure concerning capital structure and voting rights. While it relates to capital, it is primarily a mandatory disclosure of voting rights count, which is often categorized under general regulatory announcements or specific capital/share notifications. Given the options, it is a specific regulatory filing related to share capital/voting rights. Since there isn't a perfect fit for 'Total Voting Rights Disclosure', I must choose the closest category. It is not a Director's Dealing (DIRS), Major Shareholding (MRQ), or Share Issue (SHA). It is a formal regulatory notification. The closest fit among the specific options that deal with share structure/rights is 'Share Issue/Capital Change' (SHA) or the general 'Regulatory Filings' (RNS). Since it is a formal, periodic disclosure mandated by financial regulators (AMF), and it deals directly with the composition of capital and voting rights, it aligns closely with regulatory reporting. However, the content is a direct statement of the current share count and voting rights, which is a specific type of regulatory filing. Given the options, and recognizing this as a mandatory disclosure of the capital base, 'SHA' (Share Issue/Capital Change) is plausible, but 'RNS' (Regulatory Filings) is the safest fallback for specific, non-standard regulatory notices. Upon review, disclosures about the total number of voting rights are often grouped with capital structure updates. Since 'SHA' covers 'Share Issue/Capital Change', and this document reports the current state of the capital base (total shares and voting rights), I will classify it as SHA, as it is a direct report on the capital structure, even if it's not an issuance event. If SHA is too narrow, RNS is the fallback. Let's re-evaluate: This is a 'Declaration du nombre total de droits de vote' (Declaration of the total number of voting rights). This is a specific regulatory requirement often filed alongside or instead of other capital change reports. Given the strict definitions, RNS is the most appropriate general regulatory filing category when a specific one like DVA (Voting Results) or SHA (Issuance) doesn't perfectly match the content (which is a static count, not a result or an issuance). I will use RNS as the best fit for a specific, mandatory regulatory disclosure not covered elsewhere.
2023-08-03 French
LUMIBIRD : 2023 – HALF YEAR REVENUES OF €97.2M (+16%)
Earnings Release Classification · 99% confidence The document explicitly reports financial results for a specific period: "2023 - HALF YEAR REVENUES OF €97.2M (+16%)" and contains detailed consolidated revenues, segment breakdowns, and outlook statements. The date is July 24, 2023, which aligns with reporting for the first half (H1) of the year. This content structure—detailed financial performance for a period shorter than a year, including unaudited data and forward guidance—is characteristic of an Interim/Quarterly Report. It is more comprehensive than a simple Earnings Release (ER) but is not the full Annual Report (10-K). Therefore, the classification is Interim / Quarterly Report (IR). H1 2023
2023-07-24 English
LUMIBIRD : CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2023 A 97,2M€ (+16%)
Earnings Release Classification · 100% confidence The document is dated July 24, 2023, and presents 'CHIFFRE D'AFFAIRES DU 1ER SEMESTRE 2023' (First Half 2023 Revenue) with detailed tables comparing Q1, Q2, and H1 2023 results against 2022. It explicitly states the figures are 'non audité' (unaudited) and discusses business segments and outlook. This structure—a press release format announcing key financial figures for a period shorter than a year (the first semester)—is characteristic of an Earnings Release (ER). It is not the full, comprehensive Interim/Quarterly Report (IR) itself, but the initial announcement of the results, often released before the full IR document. H1 2023
2023-07-24 French
LUMIBIRD : nombre d'actions au 30 juin 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (834 characters) and presents a table titled "Informations relatives au nombre total de droits de vote et d'actions" (Information relating to the total number of voting rights and shares). It explicitly references French regulatory articles (Code de commerce and Règlement général de l'Autorité des Marchés Financiers) and provides a snapshot of the total capital, real voting rights, and theoretical voting rights as of June 30, 2023. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement, often published periodically. It does not fit the definition of a full report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given its nature as a specific, periodic regulatory disclosure that doesn't fit the other precise categories (like DIRS, DIV, or DVA), it falls best under the general 'Regulatory Filings' category (RNS) or potentially a specific capital/share structure announcement. Since it is a direct regulatory disclosure about the capital structure's voting rights, RNS is the most appropriate fallback for specific regulatory notices not covered elsewhere. It is not a declaration of voting results (DVA) but a statement of the total rights available.
2023-07-05 French
Lumibird acquiert un bloc de 50 000 actions propres auprès de sa maison mere Esira
Transaction in Own Shares Classification · 100% confidence The document explicitly announces that LUMIBIRD acquired a block of 50,000 treasury shares from its parent company ESIRA on July 5, 2023, as part of its share repurchase program. The title is "LUMIBIRD ACQUIERT UN BLOC DE 50 000 ACTIONS PROPRES AUPRES DE SA MAISON MERE ESIRA." This action—the company buying back or dealing in its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). The document details the price, the seller, and the resulting shareholding structure, confirming it is a report of a share repurchase transaction.
2023-07-05 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.